These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 22749331)
1. The neurobiology of sirtuins and their role in neurodegeneration. Donmez G Trends Pharmacol Sci; 2012 Sep; 33(9):494-501. PubMed ID: 22749331 [TBL] [Abstract][Full Text] [Related]
2. After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders. Huber K; Superti-Furga G Bioorg Med Chem; 2011 Jun; 19(12):3616-24. PubMed ID: 21306906 [TBL] [Abstract][Full Text] [Related]
3. Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications. Aljada A; Dong L; Mousa SA Curr Opin Investig Drugs; 2010 Oct; 11(10):1158-68. PubMed ID: 20872319 [TBL] [Abstract][Full Text] [Related]
4. A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 1. Kelly G Altern Med Rev; 2010 Sep; 15(3):245-63. PubMed ID: 21155626 [TBL] [Abstract][Full Text] [Related]
6. A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 2. Kelly GS Altern Med Rev; 2010 Dec; 15(4):313-28. PubMed ID: 21194247 [TBL] [Abstract][Full Text] [Related]
7. Sirtuins as possible targets in neurodegenerative diseases. Donmez G Curr Drug Targets; 2013 Jun; 14(6):644-7. PubMed ID: 23410123 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of activators and inhibitors of sirtuins. Balcerczyk A; Pirola L Biofactors; 2010; 36(5):383-93. PubMed ID: 20848588 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic role of sirtuins in neurodegenerative disease. Outeiro TF; Marques O; Kazantsev A Biochim Biophys Acta; 2008 Jun; 1782(6):363-9. PubMed ID: 18373985 [TBL] [Abstract][Full Text] [Related]
10. New assays and approaches for discovery and design of Sirtuin modulators. Schutkowski M; Fischer F; Roessler C; Steegborn C Expert Opin Drug Discov; 2014 Feb; 9(2):183-99. PubMed ID: 24382304 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol and novel potent activators of SIRT1: effects on aging and age-related diseases. Knutson MD; Leeuwenburgh C Nutr Rev; 2008 Oct; 66(10):591-6. PubMed ID: 18826454 [TBL] [Abstract][Full Text] [Related]
12. Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence. Albani D; Polito L; Forloni G J Alzheimers Dis; 2010; 19(1):11-26. PubMed ID: 20061622 [TBL] [Abstract][Full Text] [Related]
13. [Sirtuins--modulation of their activity as a novel therapeutic target]. Kucińska M; Piotrowska H; Murias M Pol Merkur Lekarski; 2010 Mar; 28(165):231-5. PubMed ID: 20815175 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial Sirtuins and Molecular Mechanisms of Aging. van de Ven RAH; Santos D; Haigis MC Trends Mol Med; 2017 Apr; 23(4):320-331. PubMed ID: 28285806 [TBL] [Abstract][Full Text] [Related]